RG7834
RG7834 (RO 7020322) is a potent, orally bioavailable small-molecule inhibitor of hepatitis B virus, demonstrating low nanomolar IC50 values against HBsAg, HBeAg, and HBV DNA in dHepaRG cell assays. It serves as a valuable research tool for investigating HBV replication mechanisms and evaluating antiviral strategies in both in vitro and in vivo models.
Product Specifications
CAS Number
2072057-17-9
Product Name Alternative
Inhibit, HBsAg, HBV, HBV DNA, HBeAg, Hepatitis B virus, Inhibitor, RO 7020322, RO7020322, RO-7020322, RG 7834, RG7834, RG-7834
Field of Research
Infectious Disease & Virology
Purity
98.00% (May vary between batches)
Solubility
DMSO:125 mg/mL (311.37 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (9.96 mM)
Smiles
COCCCOc1cc2C[C@@H] (C (C) C) n3cc (C (O) =O) c (=O) cc3-c2cc1OC
Molecular Formula
C22H27NO6
Molecular Weight
401.45
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Planaria, selected specimen stained for general study, of the body, flat w.m.
RPS6KB1 Polyclonal Antibody, PerCP Conjugated